Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03244956
Brief Title: Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer (MERAIODE)

First Submitted : August 7, 2017
First Submitted that Met QC Criteria : August 7, 2017
First Posted : August 10, 2017

Last Update Submitted that Met QC Criteria : January 2, 2019
Last Update Posted : January 3, 2019